Rights and permissions
About this article
Cite this article
No increased secondary tumour risk with single-agent methotrexate. React. Wkly. 626, 6 (1996). https://doi.org/10.2165/00128415-199606260-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-199606260-00016